跳转至内容
Merck
CN

SAB4200869

Anti-Burkholderia pyrrocinia (Pseudomonas pyrrocinia) antibody produced in rabbit

IgG fraction of antiserum

别名:

Burkholderia pyrrocinia, Pseudomonas pyrrocinia

登录 查看组织和合同定价。

选择尺寸


关于此项目

NACRES:
NA.41
UNSPSC Code:
12352203
Species reactivity:
(Burkholderia (Pseudomonas)pyrrocinia)
Species reactivity:
-
Application:
Citations:
10
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

form

liquid

species reactivity

(Burkholderia (Pseudomonas)pyrrocinia)

concentration

~1 mg/mL

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Quality Level

General description

Burkholderia pyrrocinia (previously also known as Burkholderia Pseudomonas) ) belongs to the Burkholderia cepacia complex (Bcc). Burkholderia cepacia complex is a group of at least 20 gram negative bacterial species that are widely distributed in the natural environment such as, soil and water.1 These bacteria have unusually large genomes (7.5-8.5 Mb).2 B. cepacia are opportunistic and nosocomial pathogens that affect mostly immunocompromised individuals such as cystic fibrosis (CF) patients and cause respiratory illness and chronic inflammation.3First, the bacterium initiates primary infection in the respiratory mucosa followed by spreading to adjacent organs and establishing the “cepacia syndrome.

Application

The antibody may be used in various immunochemical techniques including Immunoblotting. Detection of the Burkholderia pyrrocinia bands by Immunoblotting is specifically inhibited by the immunogen.

Biochem/physiol Actions

B. cepacia has the ability to survive intracellularly in alveolar phagocytes and respiratory epithelial cells.8 Moreover, B. cepacia produces quorum sensing (QS) molecules that control virulence factor expression and biofilm formation that shields the bacteria from immune response and antibiotic treatment.1 Bcc are resistant to various types of antibiotics such as, quinolones, aminoglycosides and β-lactams.1
Anti-Burkholderia pyrrocinia antibody recognizes B. pyrrocinia lysate and whole dead bacteria.

Physical form

Supplied as a solution in 0.01 M phosphate buffered saline pH 7.4, containing 15 mM sodium azide as a preservative.

Preparation Note

For continuous use, store at 2-8°C for up to one month. For extended storage, freeze in working aliquots. Repeated freezing and thawing is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilution samples should be discarded if not used within 12 hours.

Disclaimer

Unless otherwise stated in our catalog  our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

存储类别

12 - Non Combustible Liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

低风险生物材料
常规特殊物品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Virulence factors of Burkholderia cepacia.
J W Nelson et al.
FEMS immunology and medical microbiology, 8(2), 89-97 (1994-02-01)
Peter Vandamme et al.
Systematic and applied microbiology, 34(2), 87-95 (2011-01-25)
The Burkholderia cepacia complex is a group of closely related species with conflicting biological properties. Triggered by the devastating effect of pulmonary infections in cystic fibrosis patients, the scientific community generated an unusually large amount of taxonomic data for these
Umadevi S Sajjan et al.
Cellular microbiology, 8(9), 1456-1466 (2006-08-23)
We investigated the trafficking of Burkholderia cenocepacia, an opportunistic respiratory pathogen of persons with cystic fibrosis (CF), in immortalized CF airway epithelial cells in vitro. Our results indicate that bacteria enter cells in a process involving actin rearrangement. Whereas both
Naomi Hauser et al.
Case reports in infectious diseases, 2015, 537627-537627 (2015-09-12)
Burkholderia (formerly Pseudomonas) cepacia complex is a known serious threat to patients with cystic fibrosis, in whom it has the potential to cause the fatal combination of necrotizing pneumonia, worsening respiratory failure, and bacteremia, known as Cepacia syndrome. The potential
A Isles et al.
The Journal of pediatrics, 104(2), 206-210 (1984-02-01)
The prevalence of Pseudomonas cepacia infection increased from 10% in 1971 to 18% by 1981 in a population of approximately 500 patients with cystic fibrosis. Carriage of P. aeruginosa has remained unchanged at 70% to 80% over the same period.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持